Beyond Medical Technologies Inc. is pleased to announce that further to its news release dated January 14, 2021 announcing its letter of intent with Kayan Health Limited, Kayan Health has launched a Virtual Medical ‘Second Opinion’ platform as part of its suite of digital health products. Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company”) (CSE: DOCT) (Frankfurt: 7FM3), is pleased to announce that further to its news release dated January 14, 2021 announcing its letter of intent with Kayan Health Limited (“Kayan Health”), Kayan Health has launched a Virtual Medical ‘Second Opinion’ platform (the “Second Opinion Platform”) as part of its suite of digital health products.